In addition, we developed a peptide vaccine against ATX (VA) and assessed its efficacy in a db/db mouse model of type 2 diabetes to determine its potential as a new strategy for preventing DR. This evidence concerns the gene ENPP2 and type 2 diabetes mellitus.